Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
3 Biotech Stocks to Buy for the Next Bull Run: March 2024
06:44am, Tuesday, 26'th Mar 2024
As we step into March 2024, the spotlight is turning towards the biotech sector, with investors searching for biotech stocks to buy. Biotech stocks are ready to soar after a period of under-performanc
Vertex Pharmaceuticals (VRTX) Rises As Market Takes a Dip: Key Facts
06:55pm, Monday, 25'th Mar 2024
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $416.03, indicating a +0.09% shift from the previous trading day.
Vertex (VRTX) Continues to Diversify Beyond CF Franchise
10:10am, Monday, 25'th Mar 2024
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of its non-CF pipeline candidates.
Vertex (VRTX) Kidney Disease Drug to Enter Clinical Development
01:11pm, Friday, 22'nd Mar 2024
Vertex Pharmaceuticals (VRTX) plans to begin a phase I study on VX-407 in autosomal dominant polycystic kidney disease later this month.
Vertex Pharmaceuticals: Diversifying Its Drug Portfolio For Future Growth
12:00am, Thursday, 21'st Mar 2024
Vertex Pharmaceuticals has a dominant Cystic fibrosis franchise and plans to launch five new products by 2028, including a next-generation CF drug and a non-opioid pain management drug. VRTX stock has
3 Biopharma Stocks Predicted to Soar in Q2 2024
01:49pm, Wednesday, 20'th Mar 2024
Biopharma stocks have been among the most popular and well-performing stocks this year. With recent trends in weight loss drugs and clinical advancements in treating illnesses, this market is set for
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
02:58pm, Tuesday, 19'th Mar 2024
Given the current risk-on sentiment, it is perhaps an ideal time for investors to scoop up some of the top biotech stocks. The stock market is booming, and with investors looking to take on more risk
Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
06:56pm, Monday, 18'th Mar 2024
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $411.38, denoting a +0.91% change from the preceding trading day.
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
09:50am, Sunday, 17'th Mar 2024
Vertex Pharmaceuticals is still making progress in its core area while diversifying its lineup. HCA Healthcare's entrenched position in its industry will help it benefit from long-term trends.
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
09:00am, Sunday, 17'th Mar 2024
Investors need not be concerned about the FDA's approval delay for Eli Lilly's Alzheimer's drug. Novo Nordisk recently picked up a regulatory win that makes the stock even more attractive.
Forget Tesla, Buy This Magnificent Healthcare Stock Instead
08:54am, Sunday, 17'th Mar 2024
Tesla faces an uncertain future as rising competition and shrinking margins are putting pressure on its business. Vertex Pharmaceuticals has a bright future ahead with multiple growth catalysts, which
Vertex Pharmaceuticals Incorporated (VRTX) Leerink Partners Global Biopharma Conference (Transcript)
11:14pm, Monday, 11'th Mar 2024
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Leerink Partners Global Biopharma Conference Call March 11, 2024 4:00 PM ET Company Participants Charlie Wagner - Executive Vice President & Chief Fi
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
05:52am, Saturday, 09'th Mar 2024
Madrigal Pharmaceuticals could be days away from winning its first FDA approval. Regeneron Pharmaceuticals expects several key regulatory decisions this year.
The Top 3 Biotech Stocks to Buy in March 2024
02:45pm, Wednesday, 06'th Mar 2024
Investing in biotechnology (biotech) stocks is often thought of as being too risky for most investors. That's not necessarily the case.
Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 44th Annual Health Care Conference (Transcript)
02:52pm, Tuesday, 05'th Mar 2024
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) TD Cowen 44th Annual Health Care Conference Call March 5, 2024 10:30 AM ET Company Participants David Altshuler - Executive Vice President, Research
